HeartBeam, Inc. — Form 8-K Summary
Business context and reporting period
HeartBeam, Inc. filed this Form 8-K on November 17, 2022, reporting actions taken at a special meeting of stockholders held November 14, 2022. The filing concerns amendments to the Company’s Certificate of Incorporation and the related stockholder vote. HeartBeam’s common stock and warrants trade on Nasdaq under BEAT and BEATW, respectively.
Key financial and capitalization information
- As of the September 30, 2022 record date, 8,000,870 shares of common stock were outstanding and entitled to vote.
- 6,076,749 votes, representing approximately 75.95% of outstanding votes, were represented at the special meeting, constituting a quorum.
- The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
Material changes and stockholder approvals
- Stockholders approved an amendment increasing authorized common stock from the prior amount to 100,000,000 shares.
- Stockholders approved authorization of 10,000,000 shares of blank-check preferred stock.
- The amendment became effective upon filing and acceptance by the Delaware Secretary of State on November 16, 2022. The related exhibit is dated November 15, 2022.
| Proposal | For | Against | Abstained | Broker non-votes |
|---|---|---|---|---|
| Increase authorized common stock to 100,000,000 shares | 5,605,839 | 457,457 | 13,453 | 0 |
| Authorize 10,000,000 shares of blank-check preferred stock | 4,621,220 | 223,732 | 13,736 | 1,218,061 |
Outlook, risks, contingencies, and unusual items
The filing provides no financial guidance or management outlook. The increased authorized share capacity and blank-check preferred stock may provide flexibility for future financings, acquisitions, strategic transactions, or other corporate purposes, but the filing does not specify any planned issuance or transaction. Any future issuance could dilute existing holders or affect voting and other shareholder rights.
Important facts for investors to verify
- Confirm the Delaware filing and effective date of the Certificate of Amendment.
- Review the amendment’s specific terms, including the rights and preferences that may be designated for future preferred stock.
- Monitor future filings for issuance of additional common or preferred shares, financing activity, or related-party or strategic transactions.
- Note the timing discrepancy among the November 14 report date, November 15 exhibit date, November 16 effectiveness date, and November 17 signature date.